Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Destination India: Reconfiguring Gelatin Value Chain

Bovine Gelatin Industry Overview: The global gelatin production in 2013 was 310-320 thousand tons which is expected to grow at a CAGR of 2-3% till 2016. Globally, 26% of gelatin is bovine bone based. The yield conversion factor from bovine bone chips to gelatin is 19%. Bovine bone chips are widely used to manufacture pharmaceutical gelatin since it is more preferred due to its encapsulation properties and higher bloom which are significant in manufacturing capsules especially hard gelatin capsules for pharmaceutical and dietary supplements industry. There is a preference of using limed bone chip in the United States and blended gelatin (blends of limed bone and pigskin or limed bone, pigskin and limed hide gelatin e.g.70-80% of bone gelatine and 20-30% of limed hide gelatine) in Europe. Demand for bone chips in the US has been increasing and is expected to increase in future too.

Download '.pdf' Format of the whitepaper.

Download Whitepapers
magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024